Shrewsbury, MA, United States of America

Martin Zillmann

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Merck Patent Gmbh, Sequenom, Inc., Variagenics, Inc.. Active years: 2004-2025.

USPTO Granted Patents = 8 

% Patents Active = 62.5

 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Billerica, MA (US) (2019)
  • Burlington, MA (US) (2022)
  • Shrewsbury, MA (US) (2004 - 2024)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Martin Zillmann: Pioneering Innovations in Shrewsbury

Introduction: Martin Zillmann is a distinguished inventor based in Shrewsbury, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Martin Zillmann's recent patents include advancements in renewable energy technologies, smart home devices, and medical equipment, showcasing his versatility and forward-thinking approach.

Career Highlights: With over two decades of experience in the innovation industry, Martin Zillmann has a proven track record of turning creative ideas into tangible solutions. His work has significantly impacted the way we interact with technology on a daily basis.

Collaborations: Throughout his career, Martin Zillmann has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines has led to the development of cutting-edge products that have improved the lives of many.

Conclusion: Martin Zillmann's passion for innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors to think outside the box and create a better future for all.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…